Zanganeh Maky

Average Profitability
24.76%
Insider Buys Quantity
23
Insider Buys Sum
$33.02M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Zanganeh Maky

According to the SEC Form 4 filings, Zanganeh Maky, being in a position of

  1. Chief Executive Officer at Summit Therapeutics Inc.,
    оver the last 12 months, has bought 115321 share for $421,444, and sold 0 shares,
    over all time since 2021-05-12, has bought 25062367 shares for $28.16M, and sold 0 shares.

The largest purchase of all time was on 2023-03-08 and amounted to 23527044 shares of Summit Therapeutics Inc. for $24.7M.

Biography of Zanganeh Maky

No biography is available at this moment.

2024-03-27PurchaseSummit Therapeutics Inc.
SMMT
Chief Executive Officer
80,321
0.0113%
$3.72$298,594+143.85%
2024-03-26PurchaseSummit Therapeutics Inc.
SMMT
Chief Executive Officer
30,000
0.0043%
$3.75$112,500+140.11%
2023-12-12PurchaseSummit Therapeutics Inc.
SMMT
Chief Executive Officer
5,000
0.0007%
$2.07$10,350+110.96%
2023-03-08PurchaseSummit Therapeutics Inc.
SMMT
Co-CEO & President
23.53M
4.2977%
$1.05$24.7M+26.64%
2022-08-16PurchaseSummit Therapeutics Inc.
SMMT
Co-CEO & President
1.03M
0.6664%
$0.97$999,997+70.3%
2021-05-12PurchaseSummit Therapeutics Inc.
SMMT
Chief Operating Officer
389,077
0.4112%
$5.24$2.04M-6.4%
2020-06-23PurchasePulse Biosciences, Inc.
PLSE
director
1,193
0.0055%
$10.70$12,767+63.04%
2020-06-17PurchasePulse Biosciences, Inc.
PLSE
director
7,950
0.0268%
$7.01$55,730+79.81%
2017-12-13PurchasePulse Biosciences, Inc.
PLSE
director
1,100
0.0066%
$23.98$26,378-36.94%
2017-12-12PurchasePulse Biosciences, Inc.
PLSE
director
1,000
0.006%
$23.98$23,979-36.78%
2017-12-11PurchasePulse Biosciences, Inc.
PLSE
director
3,000
0.0172%
$22.76$68,289-36.61%
2017-09-18PurchasePulse Biosciences, Inc.
PLSE
director
7,775
0.0559%
$15.02$116,791+22.35%
2017-09-14PurchasePulse Biosciences, Inc.
PLSE
director
22,000
0.1305%
$12.77$280,879+18.67%
2017-08-03PurchasePulse Biosciences, Inc.
PLSE
director
20,500
0.1407%
$23.48$481,332-21.36%
2017-08-02PurchasePulse Biosciences, Inc.
PLSE
director
8,290
0.0572%
$25.15$208,469-25.94%
2017-05-11PurchasePulse Biosciences, Inc.
PLSE
director
30,000
0.2014%
$20.84$625,080+3.05%
2017-05-10PurchasePulse Biosciences, Inc.
PLSE
director
10,000
0.0727%
$21.71$217,090+7.13%
2017-05-09PurchasePulse Biosciences, Inc.
PLSE
director
67,520
0.4339%
$20.16$1.36M+1.97%
2017-03-20PurchasePulse Biosciences, Inc.
PLSE
director
21,560
0.1537%
$22.66$488,450+1.74%
2017-03-17PurchasePulse Biosciences, Inc.
PLSE
director
19,920
0.1404%
$23.83$474,748-4.33%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.